Graco (GGG)
(Delayed Data from NYSE)
$86.21 USD
-0.51 (-0.59%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $86.22 +0.01 (0.01%) 6:08 PM ET
4-Sell of 5 4
F Value B Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$86.21 USD
-0.51 (-0.59%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $86.22 +0.01 (0.01%) 6:08 PM ET
4-Sell of 5 4
F Value B Growth C Momentum D VGM
Zacks News
Why Earnings Season Could Be Great for Graco (GGG)
by Zacks Equity Research
Graco (GGG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Colfax (CFX) Shares Gain 41% in 3 Months: What's Driving It?
by Zacks Equity Research
Colfax (CFX), with 41% growth in shares in the past three months, benefits from the overall revival in the broader market, buyout impacts, solid product offerings and cost-saving measures.
Graco (GGG) Introduces New Line of Disinfectant Sprayer
by Zacks Equity Research
Graco's (GGG) new line of SaniSpray HP airless sprayers help in delivering the proper particle atomization and specified disinfectant dwell times on all surfaces.
Reasons Why It is Better to Avoid Investing in Graco Stock Now
by Zacks Equity Research
Graco (GGG) suffers from the adverse impacts of the pandemic. It suspends projections for 2020. Forex woes and margin-related headwinds are also concerning.
Graco Enhances Product Portfolio With GrindLazer Scarifiers
by Zacks Equity Research
Graco's (GGG) three new high-production GrindLazer drum scarifiers help in performing heavy-duty tasks like grooving, leveling, inlay, scarifying and stripping coatings.
Graco Launches E-Flo iQ Adhesive & Sealant Dispense System
by Zacks Equity Research
Graco's (GGG) E-Flo iQ adhesive and sealant dispense system helps in the regulation of bead accuracy from the pump to the dispense point efficiently.
Graco's HydroShield Waterborne System to Aid in Spraying Tasks
by Zacks Equity Research
Graco's (GGG) HydroShield Waterborne System is developed to help manufacturers in simplifying waterborne material-spraying tasks.
Colfax (CFX) Declines 23% YTD: What's Hurting the Stock?
by Zacks Equity Research
Colfax (CFX), with a 23% decline in shares so far in 2020, faces the adverse impacts of the pandemic. High debts and forex woes are other concerns. However, cost-reduction actions might aid.
Moving Average Crossover Alert: Graco
by Zacks Equity Research
Graco Inc. (GGG) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Graco (GGG) Lags Q1 Earnings Estimates, Withdraws Sales View
by Zacks Equity Research
Graco's (GGG) first-quarter earnings suffer from weak revenue generation and a decline in margins. It suspends revenue projections for the year due to economic uncertainties.
Industrial Stock Q1 Earnings Due on Apr 22: GGG, MSA & More
by Zacks Equity Research
The impacts of the coronavirus outbreak and countermeasures, cost-related woes, and other headwinds might get reflected in Q1 results of the majority of industrial stocks.
Here's Why Investors Should Ignore Flowserve (FLS) for Now
by Zacks Equity Research
Flowserve's (FLS) operations are exposed to uncertainties caused by the coronavirus outbreak. Also, high debts, realignment expenses and forex woes might be concerning.
Nordson (NDSN) Gains From Buyouts Despite Segmental Woes
by Zacks Equity Research
Nordson (NDSN) is likely to benefit from strength in its medical product end markets, growth initiatives and buyouts. Weak Advanced Technology Systems segment and high cost of sales remain concerning.
Applied Industrial Gains From Buyouts Despite Market Woes
by Zacks Equity Research
Applied Industrial (AIT) to gain from cost-saving measures, acquisitions and shareholder-friendly policies. Softness in industrial demand might impact near-term results.
Colfax (CFX) Displays Bright Prospects, Headwinds Remain
by Zacks Equity Research
Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses, productivity actions and acquisitions. However, rising cost of sales and high debt remain concerns.
3M (MMM) Collaborates With Ford to Combat Coronavirus Crisis
by Zacks Equity Research
3M (MMM) partners with Ford to increase the production of powered air purifying respirators in its bid to contribute toward the fight against the coronavirus pandemic.
Crane (CR) to Benefit From Acquisitions, Headwinds Persist
by Zacks Equity Research
Crane (CR) is likely to benefit from its focus on product development, strong operating leverage, repositioning activities and acquired asset. However, high debt and segmental woes remain concerns.
Honeywell Increases Face Mask Production to Fight Coronavirus
by Zacks Equity Research
Honeywell (HON) increases production of healthcare materials in its bid to contribute toward the fight against the coronavirus pandemic.
iRobot (IRBT) Withdraws Annual View on Coronavirus Concerns
by Zacks Equity Research
Due to the pandemic, iRobot (IRBT) lowers sales view for first-quarter 2020 and withdraws annual projections. It expects to witness relief if Roomba products get excluded from Section 301 tariffs.
Enersys Gains From Solid Demand & Buyouts Amid Cost Woes
by Zacks Equity Research
Enersys (ENS) benefits from strength in its transportation business, solid demand for NexSys TPPL products and buyout of Alpha Technologies. However, rising cost of sales and high debt remain concerns.
Enerpac Tool (EPAC) Lags on Q2 Earnings, Discontinues View
by Zacks Equity Research
Enerpac Tool (EPAC) Q2 results reflect weak sales and operating performance. It discontinues the fiscal 2020 projections due to volatility in oil prices and the coronavirus outbreak.
Cintas (CTAS) Q3 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Cintas' (CTAS) third-quarter fiscal 2020 earnings and revenues increase year over year due to strong performance in its segmental businesses.
IDEX (IEX) Authorizes Share Repurchase Program Worth $500M
by Zacks Equity Research
IDEX's (IEX) approval of an additional share repurchase program worth $500 million is likely to instill confidence among investors.
Honeywell Unveils Analytics Platform for Aviation Industry
by Zacks Equity Research
Honeywell's (HON) Forge platform empowers aviation customers with a user friendly, integrated dashboard that helps in sending instant alerts on issues related to connectivity and flight plan changes.
Dover (DOV) to Buy Em-tec, Sees Growth in Biopharma Market
by Zacks Equity Research
The latest acquisition will help Dover (DOV) expand its offerings into biopharma and other hygienic applications.